Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
Go back to Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®| Perrigo (NYSE: PRGO) | Delayed: 14.54 -0.38 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.92 | 52 Week High | $156.03 | |||
| Open | $14.81 | 52 Week Low | $79.72 | |||
| Day High | $14.89 | P/E | N/A | |||
| Day Low | $14.48 | EPS | $0.00 | |||
| Volume | 1,458,286 | |||||
| Perrigo (NYSE: PRGO) | Delayed: 14.54 -0.38 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.92 | 52 Week High | $156.03 | |||
| Open | $14.81 | 52 Week Low | $79.72 | |||
| Day High | $14.89 | P/E | N/A | |||
| Day Low | $14.48 | EPS | $0.00 | |||
| Volume | 1,458,286 | |||||

